Moderna | MRNA - نسبة السعر إلى الأرباح

سعر السهم
47.12
التغيير اليومي
-1.58 -3.24%
شهريا
-2.30%
سنويا
69.37%
Q2 التوقعات
49.64




Pe تغيير تاريخ
Acadia Pharmaceuticals 11.61 2.09 2025-12
Agios Pharmaceuticals 3.56 0.68 2025-09
Alnylam Pharmaceuticals 170.7 367.33 2025-12
Amgen 25.31 15.82 2025-12
Biogen 14.02 4.63 2025-12
BioMarin Pharmaceutical 19.24 0.21 2025-12
Celltrion 50.09 23.24 2025-09
Cspc Pharmaceutical 24.4 1.13 2025-12
Deva Holding AS 6.55 2.01 2023-09
Dianthus Therapeutics 3.8 1.53 2024-09
Divis Laboratories Ltd 66.5 5.69 2025-12
Esperion Therapeutics 129.79 129 2024-12
Gilead Sciences 15.63 0.08 2025-12
GlaxoSmithKline 11.15 0.29 2025-12
Incyte 14.84 2.79 2025-12
Ionis Pharmaceuticals 396.15 79.28 2022-09
Kangmei Pharma 3.15K 624.19 2025-06
Knight Therapeutics 257.34 166.24 2025-12
Laboratorios Farma 18.78 6.64 2023-12
Malin Corporation 11.81 0.72 2023-06
Moderna 27.22 14.51 2023-06
Organigram Holdings 235 224.49 2025-09
Ovoca Bio 1.83 3.29 2024-06
Pharma Mar 17.41 29.74 2025-12
Puma Biotechnology 13.93 44.88 2024-06
Qiagen NV 20.54 0.1 2025-12
Regeneron Pharmaceuticals 18.11 2.91 2025-12
Sarepta Therapeutics 27.27 0 2025-09
Sartorius 43.44 84.64 2026-03
Sino Biopharmaceutical 17.03 0.89 2025-06
Tilray 11.56 80.19 2025-09
United Therapeutics 17.32 1.62 2025-12
Vertex Pharmaceuticals 26.15 2.22 2025-12
Zealand Pharma A/S 5.13 0.16 2025-12
Zz Pientze Pharmaceu 49.04 4.33 2025-09